Biobank for Inflammatory Chronic Diseases and Osteoporosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorUniversity Hospital, Toulouse
About this trial
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
With National Health Assurance
Able to consent to the study
Disqualifiers
Pregnancy or breastfeeding
Not able to give a consent
Severe anemia (Hb<10g/L)
Trial population
monocentric observational longitudinal study
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Blood sampling
Biological/Vaccine4 tubes of 7 mL will be sampled
Treatment groups
2,000 Participants
are divided into 2 treatment groupsGroup A: patients initiating a biotherapy or a target treatment1 intervention
Group B: patients with chronic inflammatory rheumatism, weakening osteopathy or mechanical pathology1 intervention
Trial outcomes
Primary outcomes
1
EULAR response after 3 months
EULAR response after 3 months
Time frame
after 3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov